Comparative study of disc diffusion and microdilution methods in susceptibility testing of micafungin against Candida species

被引:6
作者
Ramirez, M.
Serrano, M. C.
Castro, C.
Lopez, E.
Almeida, C.
Fernandez, A.
Romero, A.
Martin-Mazuelos, E. [1 ]
机构
[1] Hosp Univ Valme, Serv Microbiol Clin, Seville 41014, Spain
[2] Hosp Univ Valme, Unidad Invest, Serv Bioestadist, Seville, Spain
关键词
susceptibility testing; antifungals; lipopeptides;
D O I
10.1093/jac/dkl335
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To compare the Clinical Laboratory Standards Institute CLSI M44-A disc diffusion (DD) and M27-A2 broth microdilution (MD) methods for determining the susceptibility of Candida spp. to micafungin (FK463). Patients and methods: A total of 355 clinical yeast isolates including 270 Candida albicans, 45 Candida glabrata, 24 Candida krusei, 11 Candida tropicalis and 5 Candida parapsilosis were studied. The MIC of micafungin was determined by following the CLSI M27-A2 guidelines (MD). Endpoints were defined as the lowest concentration of micafungin resulting in partial inhibition (IC50) of visual growth after 24/48 h of incubation at 35 degrees C. Final concentrations were 0.008-4 mg/L of micafungin. DD testing was performed using a CLSI M44-A document with 2.5 mu g micafungin discs. Zone diameter endpoints were read after 24/48 h of incubation at 35 degrees C. Arbitrary breakpoints were 4 mg/L for MD and 15 mm for DD. Results: The best correlation was observed when we read MD 48 h/DD 24 and 48 h (97%). When the reading was MD 24 h/DD 24 and 48 h the percentage of correlation was 95.2%. Conclusions: The DD method performs well for testing the susceptibility of Candida spp. to micafungin. More studies involving more Candida strains with elevated MIC values are needed.
引用
收藏
页码:861 / 863
页数:3
相关论文
共 50 条
[41]   Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods [J].
Pfaller, Michael A. ;
Watanabe, Naoaki ;
Castanheira, Mariana ;
Messer, Shawn A. ;
Jones, Ronald N. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (11) :2581-2584
[42]   AN EVALUATION OF 7 METHODS OF IN-VITRO SUSCEPTIBILITY TESTING OF CLINICAL YEAST ISOLATES AGAINST FLUCONAZOLE [J].
SCHMALRECK, AF ;
KOTTMANN, I ;
REISER, A ;
RUFFER, U ;
SCHARR, E ;
VANCA, E .
MYCOSES, 1995, 38 :55-63
[43]   Comparison of Commercial Methods and the CLSI Broth Microdilution to Determine the Antifungal Susceptibility of Candida parapsilosis Complex Bloodstream Isolates from Three Health Institutions in Rio de Janeiro, Brazil [J].
Maria Helena G. Figueiredo-Carvalho ;
Leonardo S. Barbedo ;
Manoel M. E. Oliveira ;
Fábio Brito-Santos ;
Rodrigo Almeida-Paes ;
Rosely M. Zancopé-Oliveira .
Mycopathologia, 2014, 178 :27-35
[44]   Comparison of Commercial Methods and the CLSI Broth Microdilution to Determine the Antifungal Susceptibility of Candida parapsilosis Complex Bloodstream Isolates from Three Health Institutions in Rio de Janeiro, Brazil [J].
Figueiredo-Carvalho, Maria Helena G. ;
Barbedo, Leonardo S. ;
Oliveira, Manoel M. E. ;
Brito-Santos, Fabio ;
Almeida-Paes, Rodrigo ;
Zancope-Oliveira, Rosely M. .
MYCOPATHOLOGIA, 2014, 178 (1-2) :27-35
[45]   Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates [J].
Smith, Elizabeth C. ;
Brigman, Hunter, V ;
Anderson, Jadyn C. ;
Emery, Christopher L. ;
Bias, Tiffany E. ;
Bergen, Phillip J. ;
Landersdorfer, Cornelia B. ;
Hirsch, Elizabeth B. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (10)
[46]   Levofloxacin susceptibility testing against Helicobacter pylori: evaluation of a modified disk diffusion method compared to E test [J].
Boyanova, Lyudmila ;
Ilieva, Juliana ;
Gergova, Galina ;
Mitov, Ivan .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 84 (01) :55-56
[47]   Disc diffusion susceptibility testing of Haemophilus influenzae by NCCLS methodology using low-strength ampicillin and co-amoxiclav discs [J].
Kärpänoja, P ;
Nissinen, A ;
Huovinen, P ;
Sarkkinen, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (04) :660-663
[48]   Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida Time for harmonization of CLSI and EUCAST broth microdilution methods [J].
Pfaller, M. A. ;
Andes, D. ;
Diekema, D. J. ;
Espinel-Ingroff, A. ;
Sheehan, D. .
DRUG RESISTANCE UPDATES, 2010, 13 (06) :180-195
[49]   Comparison of susceptibility testing methods for determining the activity of colistin against Gram-negative bacilli of clinical origin [J].
Haeili, Mehri ;
Kafshdouz, Mahsa ;
Pishnian, Zeinab ;
Feizabadi, Mohammad Mehdi ;
Martinez-Martinez, Luis .
JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (01) :60-66
[50]   A COMPARATIVE-EVALUATION OF 3 METHODS OF ANTIVIRAL SUSCEPTIBILITY TESTING OF CLINICAL HERPES-SIMPLEX VIRUS ISOLATES [J].
SAFRIN, S ;
PHAN, L ;
ELBEIK, T .
CLINICAL AND DIAGNOSTIC VIROLOGY, 1995, 4 (01) :81-91